Gene: ACAT2
Official Full Name: acetyl-CoA acetyltransferase 2provided by HGNC
Gene Summary: The product of this gene is an enzyme involved in lipid metabolism, and it encodes cytosolic acetoacetyl-CoA thiolase. This gene shows complementary overlapping with the 3-prime region of the TCP1 gene in both mouse and human. These genes are encoded on opposite strands of DNA, as well as in opposite transcriptional orientation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO39135 | ACAT2 Knockout cell line (HeLa) | Human | ACAT2 | 1:3~1:6 | Negative | Online Inquiry |
KO39136 | ACAT2 Knockout cell line (HCT 116) | Human | ACAT2 | 1:2~1:4 | Negative | Online Inquiry |
KO39137 | ACAT2 Knockout cell line (HEK293) | Human | ACAT2 | 1:3~1:6 | Negative | Online Inquiry |
KO39138 | ACAT2 Knockout cell line (A549) | Human | ACAT2 | 1:3~1:4 | Negative | Online Inquiry |
ACAT2 Gene Knockout Cell Lines represent a revolutionary approach in cellular biology and genetic research, specifically designed to facilitate the study of acyl-CoA:cholesterol acyltransferase 2 (ACAT2) gene function. These cell lines are genetically modified to lack the ACAT2 gene, which plays a crucial role in lipid metabolism, particularly in the esterification of cholesterol and fatty acids. By utilizing techniques such as CRISPR/Cas9 gene editing, the knockout of ACAT2 allows for the investigation of its involvement in cellular processes, such as lipid droplet formation, cholesterol homeostasis, and inflammatory responses.
The mechanisms at play in ACAT2 knockout cell lines center around enhanced lipid profiling and metabolic assays, allowing researchers to observe the consequences of ACAT2 deficiency in real-time. This capability not only aids in elucidating the gene's biological roles but also contributes to our understanding of associated metabolic disorders, cardiovascular diseases, and obesity. In clinical settings, these models can serve as invaluable tools for drug discovery, toxicology studies, and investigating potential therapeutic targets for diseases linked to altered lipid metabolism.
Compared to traditional cell lines, ACAT2 Knockout Cell Lines provide a unique advantage by offering a specific, validated system to explore the direct implications of ACAT2 deletion without the noise of other metabolic influences. This specificity and clarity in research outcomes enhance reproducibility and reliability, thus maximizing research efficiency.
Researchers and clinicians benefit significantly from the insights gained from these cell lines, which are applicable across a range of studies, from basic research to translational applications in therapeutic development. Understanding the regulatory mechanisms of ACAT2 can lead to novel intervention strategies targeting lipid-related maladies, making these cell lines a critical resource.
Our company prides itself on expertise in genetic engineering and cell line development, providing researchers with advanced tools that drive scientific innovation. With our commitment to quality and reliability, we ensure that our ACAT2 Gene Knockout Cell Lines support your critical research endeavors with the utmost precision.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.